MEBO Group Meets with President of Vietnam to Deepen Regional Innovation and Healthcare Cooperation

On October 30, during the APEC 2025 Summit in Gyeongju, Korea, a high-level MEBO Group delegation led by Li Li, Co-Founder and Vice Chair of the Board, and Vice President Liu Gang, held a bilateral meeting with H.E. Luong Cuong, President of Vietnam. The discussion centered on strengthening cooperation in technology innovation, talent development, pharmaceutical access, and local investment under the APEC framework.

Li Li (right), Vice Chair of the Board of MEBO Group, meets cordially with H.E. Luong Cuong (left), President of Vietnam

The meeting was coordinated by Kevin Xu, Chairman of the Board of MEBO Group and Executive Committee Member of the Bay Area Council, who was unable to attend in person due to his keynote speech at the APEC CEO Summit. Bay Area Council Vice President Alex Foard also joined the delegation, underscoring MEBO’s commitment to advancing U.S.–Asia-Pacific collaboration.

During the meeting, Li Li introduced MEBO’s global achievements and emphasized the company’s vision to bring its regenerative medical technologies and pharmaceutical products to Vietnam. She expressed the hope of deepening cooperation with Vietnam’s government and healthcare institutions, and of organizing a MEBO delegation to the 2027 APEC Summit in Vietnam.

President Luong Cuong congratulated MEBO on its international accomplishments, noting that Vietnam highly values partnerships that promote healthcare and sustainable development. He affirmed that Vietnam welcomes MEBO’s investment and will provide policy support to ensure mutual growth and success.

The meeting concluded in a cordial atmosphere, marking a significant milestone in MEBO Group’s regional engagement strategy and laying the foundation for deeper cooperation with Vietnam and other APEC economies.

 

---

 

About MEBO

Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.

At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.

As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.